Cryoglobulinemia secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Iqra Qamar (talk | contribs) |
Iqra Qamar (talk | contribs) |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Secondary prevention of cryoglobulinemia may include avoiding exposure to cold stimuli. Schistosoma mansoni coinfection may have a protective effect against mixed cryoglobulinaemia in hepatitis C patients. | |||
==Secondary Prevention== | ==Secondary Prevention== | ||
Revision as of 21:35, 30 April 2018
|
Cryoglobulinemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cryoglobulinemia secondary prevention On the Web |
|
American Roentgen Ray Society Images of Cryoglobulinemia secondary prevention |
|
Risk calculators and risk factors for Cryoglobulinemia secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Secondary prevention of cryoglobulinemia may include avoiding exposure to cold stimuli. Schistosoma mansoni coinfection may have a protective effect against mixed cryoglobulinaemia in hepatitis C patients.
Secondary Prevention
- Secondary prevention of cryoglobulinemia may include
- Avoiding exposure to cold stimuli
- Schistosoma mansoni coinfection may have a protective effect against mixed cryoglobulinaemia in hepatitis C patients[1]
References
- ↑ Abbas OM, Omar NA, Zaghla HE, Faramawi MF (August 2009). "Schistosoma mansoni coinfection could have a protective effect against mixed cryoglobulinaemia in hepatitis C patients". Liver Int. 29 (7): 1065–70. doi:10.1111/j.1478-3231.2009.01970.x. PMID 19192170.